GLWLF (Glow LifeTech) 5-Year EBITDA Growth Rate: 20.10% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Glow LifeTech 5-Year EBITDA Growth Rate?

Glow LifeTech GLWLF +20.03% 5-Year EBITDA Growth Rate is 20.10% as of Mar. 2026. The stock has 1 warning sign investors should review.

Glow LifeTech's EBITDA per Share for the three months ended in Mar. 2026 was $0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 55.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 20.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Glow LifeTech was 56.30% per year. The lowest was -124.60% per year. And the median was -20.85% per year.

Glow LifeTech  (OTCPK:GLWLF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Glow LifeTech 5-Year EBITDA Growth Rate Related Terms

GLWLF vs VRTX, REGN, RVMD: 5-Year EBITDA Growth Rate Comparison

For the Biotechnology subindustry, Glow LifeTech's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Glow LifeTech 5-Year EBITDA Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glow LifeTech's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Glow LifeTech's 5-Year EBITDA Growth Rate falls into.


Glow LifeTech 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 20.10% mean?
Glow LifeTech (GLWLF) has a 5-Year EBITDA Growth Rate of 20.10% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Glow LifeTech and its competitors.
Is Glow LifeTech's 5-Year EBITDA Growth Rate too high?
Glow LifeTech's current 5-Year EBITDA Growth Rate is 20.10%.
How does Glow LifeTech's 5-Year EBITDA Growth Rate compare to VRTX and REGN?
Glow LifeTech's 5-Year EBITDA Growth Rate of 20.10% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Biotechnology company?
A good 5-Year EBITDA Growth Rate depends on the Biotechnology industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Glow LifeTech and its competitors. Glow LifeTech's current 5-Year EBITDA Growth Rate is 20.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glow LifeTech stock overvalued right now?
Glow LifeTech (GLWLF) has a current 5-Year EBITDA Growth Rate of 20.10%. The current 5-Year EBITDA Growth Rate is 20.10%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Glow LifeTech (GLWLF), the current 5-Year EBITDA Growth Rate is 20.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Glow LifeTech Business Description

Other Exchanges 9DO:GermanyGLOW:Canada
Address 65 International Boulevard, Suite 103, Etobicoke, ON, CAN, M9W 6L9
Glow LifeTech Corp is a biotechnology company engaged in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.